Novel fh mutations in families with hereditary leiomyomatosis and renal cell cancer (hlrcc) and patients with isolated type 2 papillary renal cell carcinoma

HIGHLIGHTS

• who: Betty Gardie and collaborators from the Cancer Institute de Médecine Paris-Sud, Le Kremlin-Bicêtre, France have published the research: Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma, in the Journal: (JOURNAL)
• what: This study reports the identification and analysis of FH mutations, including 21novel, in 40 families with MCUL/HLRCC and, for the first time, in 4 patients with isolated PRCCII.
• how: The authors compared the FH enzymatic activity of cells from patients of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.